FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Gov. DeSantis declares a State of Emergency in FL for Hurricane Dorian
August 29, 2019

Under a State of Emergency, a pharmacist, in his or her professional judgment, may be able to refill prescriptions early. Continue reading


Fourth Quarterly Performance Report Released for the 2018-2019 Fiscal Year
August 23, 2019

The Quarterly Performance Report for the fourth quarter of the 2018-2019 fiscal year is now available online. Continue reading